Johnson & Johnson broke its promises to investors in Auris Health, a surgical robotics startup it bought five years ago for $3.4 billion. Now it must shell out another $1 billion, based on a ruling yesterday from Delaware Chancery Court.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,